Vaccines hope takes Bavarian Nordic's share price to more than 300 DKK

Monday saw lots of activity on Bavarian Nordic equity. According to a Danish bank analyst this owes to the potential of the firm's Covid-19 vaccine and a new order for the firm's smallpox vaccine.
Photo: Bavarian Nordic / PR
Photo: Bavarian Nordic / PR

A Canadian order for smallpox vaccines worth DKK 195m (USD 31.3m) and continued speculation surrounding Bavarian Nordic's Covid-19 vaccine's glorious future has caused its share price to skyrocket in early Monday trading.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading